Hongliang He

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics.
  2022 L1 75/100

1 assessed by us (1 reproduced) · 25 not yet assessed — every PubMed paper on record, linked below.

• Receptor binding domain-independent pancoronavirus vaccine design by fusion of conserved T/B Epitopes ↗

  Emerging Microbes & Infections · 2026 · PMID 41672103
  not yet assessed
• Persistent inflammatory markers existing with HIV-1 reservoirs in antiretroviral therapy treated HIV-1 individuals ↗

  Cytokine · 2026 · PMID 41662819
  not yet assessed
• Receptor binding domain-independent pancoronavirus vaccine design by fusion of conserved T/B Epitopes ↗

  Figshare · 2026
  not yet assessed
• Receptor binding domain-independent pancoronavirus vaccine design by fusion of conserved T/B Epitopes ↗

  Figshare · 2026
  not yet assessed
• A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing ↗

  Nature Communications · 2025 · PMID 40328740
  not yet assessed
• Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough ↗

  European journal of medical research · 2025 · PMID 39757187
  not yet assessed
• 0999 Tape strip transcriptomic analysis of Thai patients with atopic dermatitis shows greater immune and barrier abnormalities in the setting of comorbid food allergy ↗

  Journal of Investigative Dermatology · 2025
  not yet assessed
• Are the original SARS‐CoV‐2 novel mutants from in vitro culture able to escape the immune response? ↗

  Journal of Medical Virology · 2023 · PMID 37448226
  not yet assessed
• A survey and antibody test following the surge of SARS-CoV-2 Omicron infection in China ↗

  medRxiv · 2023
  not yet assessed
• Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics

  Frontiers in Microbiology · 2022 · PMID 35983322
  L1 75/100
• Corrigendum to “Biochemical characterization of SARS-CoV-2 nucleocapsid protein” ↗

  Biochemical and Biophysical Research Communications · 2022 · PMID 35643631
  not yet assessed
• Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis ↗

  ACS Sensors · 2021 · PMID 34263598
  not yet assessed
• Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies ↗

  Frontiers in Immunology · 2021 · PMID 34484190
  not yet assessed
• Digital PCR assay for the effective detection of COVID-19 patients with SARS-CoV-2 low viral load ↗

  Journal of Virological Methods · 2021 · PMID 34051244
  not yet assessed
• Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2 ↗

  Frontiers in Immunology · 2021 · PMID 34539645
  not yet assessed
• Mutation and Virulence of SARS-CoV-2 Strains Circulating in Anhui Province, China ↗

  SSRN Electronic Journal · 2021
  not yet assessed
• Transcriptome Profiling of Peripheral Blood Mononuclear Cells Reveals COVID-19 Patients Are Not Recovered to Normal After Discharge for 5 Months ↗

  Research Square · 2021
  not yet assessed
• Biochemical characterization of SARS-CoV-2 nucleocapsid protein ↗

  Biochemical and Biophysical Research Communications · 2020 · PMID 32416961
  not yet assessed
• Serum IgA, IgM, and IgG responses in COVID-19 ↗

  Cellular and Molecular Immunology · 2020 · PMID 32467617
  not yet assessed
• Characteristics of patients with coronavirus disease (COVID‐19) confirmed using an IgM‐IgG antibody test ↗

  Journal of Medical Virology · 2020 · PMID 32330303
  not yet assessed
• Risk-adapted Treatment Strategy For COVID-19 Patients ↗

  International Journal of Infectious Diseases · 2020 · PMID 32229257
  not yet assessed
• Diagnostic accuracy of serological tests and kinetics of severe acute respiratory syndrome coronavirus 2 antibody: A systematic review and meta‐analysis ↗

  Reviews in Medical Virology · 2020 · PMID 33152146
  not yet assessed
• Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19 ↗

  Frontiers in Immunology · 2020 · PMID 32983180
  not yet assessed
• COVID-19 diagnosis and study of serum SARS-CoV-2 specific IgA, IgM and IgG by chemiluminescence immunoanalysis ↗

  medRxiv · 2020
  not yet assessed
• Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China ↗

  medRxiv · 2020
  not yet assessed
• 253 RNA-seq profiling of tape strips from infants with atopic dermatitis show profound barrier and immune abnormalities ↗

  Journal of Investigative Dermatology · 2020
  not yet assessed